Episode #104

British Invasion: NY-Based Pfizer Wants to Move to the United Kingdom

« previous episode | next episode »

Friday, May 02, 2014

New York-based pharmaceutical giant Pfizer wants to move to the United Kingdom. The company revealed a multi-billion dollar offer to acquire British rival AstraZeneca and if the acquisition is successful, Pfizer plans to reincorporate in there. Doing so would lower the company's tax rate from approximately 27 percent in the U.S. to 20 percent next year in the U.K. The move would also allow Pfizer to avoid paying U.S. taxes on profits made overseas. This week on Money Talking, regular contributors Rana Foroohar of Time magazine and Joe Nocera of the New York Times discuss if Pfizer could inspire other U.S.-based, international companies to pursue a similar path. Plus, a look at the saga of Los Angeles Clippers owner Donald Sterling whose racist comments prompted the NBA to ban him for life and what it means for business

Hosted by:

Charlie Herman

Produced by:

Daniel P. Tucker


Rana Foroohar and Joe Nocera

Leave a Comment

Email addresses are required but never displayed.

Get the WNYC Morning Brief in your inbox.
We'll send you our top 5 stories every day, plus breaking news and weather.